- Global Pharma News & Resources

Low Back Pain (Central Nervous System) Pipeline Review, H2 2018 -

The "Low Back Pain - Pipeline Review, H2 2018" drug pipelines has been added to's offering.

Low Back Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 6, 12, 3, 4 and 1 respectively.

Low Back Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Low Back Pain - Overview
  3. Low Back Pain - Therapeutics Development
  4. Low Back Pain - Therapeutics Assessment
  5. Low Back Pain - Companies Involved in Therapeutics Development
  6. Low Back Pain - Drug Profiles
  7. Low Back Pain - Dormant Projects
  8. Low Back Pain - Discontinued Products
  9. Low Back Pain - Product Development Milestones
  10. Appendix

Companies Mentioned

  • Ache Laboratorios Farmaceuticos SA
  • Adynxx Inc
  • AnGes Inc
  • Array BioPharma Inc
  • Axsome Therapeutics Inc
  • Camurus AB
  • Daewon Pharm Co Ltd
  • Egalet Corp
  • Frontier Biotechnologies Inc
  • Gador SA
  • Hisamitsu Pharmaceutical Co Inc
  • Immune Pharmaceuticals Inc
  • Inspyr Therapeutics Inc
  • MD Biosciences GmbH
  • Mesoblast Ltd
  • Nektar Therapeutics
  • Pacira Pharmaceuticals Inc
  • Pfizer Inc
  • Regeneron Pharmaceuticals Inc
  • Stayble Therapeutics AB
  • Therapix Biosciences Ltd
  • WEX Pharmaceuticals Inc

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 19-Oct-2018